COVID-19
Diagnostics resource centre

FIND is working in partnership with WHO to accelerate development and access to diagnostics as part of the global response to the COVID-19 pandemic.

This diagnostics resource centre is designed to support policymakers and healthcare providers with up-to-date information on tests and testing for SARS-CoV-2 (the causative agent of COVID-19).

NEW: SARS-COV-2 AG RDT TRAINING PACKAGE V1.0

The SARS-CoV-2 antigen rapid diagnostic test (SARS-CoV-2 Ag RDT) training package – designed and developed by FIND and WHO – is a structured comprehensive collection of training resources and tools to support relevant institutions to organize, run and evaluate training of trainers and/or training of health workers who will be performing SARS-CoV-2 testing using Ag RDTs.

The training package can be used in face-to-face training or as a blend of remote face-to-face training. Materials can be adapted and customized based on national guidelines and target group of participants.

Independent test evaluations

We are conducting independent evaluations of molecular tests and immunoassays, in collaboration with WHO, the Hôpitaux Universitaires de Genève and others, to assist in-country decision making. Data from these evaluations will be made publicly available.

FIND SARS-COV-2 MOLECULAR ASSAY EVALUATIONS

FIND SARS-COV-2 IMMUNOASSAY EVALUATIONS

SARS-COV-2 Diagnostic perfomance data

“Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.”

 

Link to page

SARS-CoV-2 DIAGNOSTIC
PIPELINE

We are continually updating our searchable database showing the current status of SARS-CoV-2 tests in development and commercialized.

SARS-COV-2
DIAGNOSTIC PIPELINE

SARS-CoV-2 DIAGNOSTIC
PERFORMANCE DATA

We are collating and centralizing performance data on commercially available in vitro diagnostic tests for SARS-CoV-2 as a global public good.

SARS-COV-2
DIAGNOSTIC PERFORMANCE DATA

SARS-CoV-2 DIAGNOSTIC
USE CASES

Nine diagnostic use cases for SARS-CoV-2 tests have been developed by our partners at Halteres Associates with our input.

SARS-COV-2
DIAGNOSTIC USE CASES

Current testing situation worldwide

Our interactive map tracks the number of SARS-CoV-2 tests reported to have been performed in each country, and compares it with the number that showed a positive result, to build a picture of how many people in the world are being tested for COVID-19.

INTERACTIVE SARS-CoV-2 TEST-TRACKER

Online training
COVID-19 diagnostics and testing

In partnership with ASLM and LSHTM, we are developing an online training course on diagnostics for the COVID-19 response, hosted by FutureLearn. The course is designed for Ministry of Health officials, laboratory professionals, clinicians and anyone involved in laboratory testing and diagnosis for COVID-19, with a focus on low- and-middle-income settings. Enrolment is now open and the course will commence on 20 April 2020.

more information & enrol here

Media & press

Media & press

Diagnostic testing for severe acute respiratory syndrome–related Coronavirus-2: A narrative review
Read more
In Scramble for Coronavirus Supplies, Rich Countries Push Poor Aside
Read more
Fast, portable tests come online to curb coronavirus pandemic
Read more
AIDS, TB And Malaria: Coronavirus Threatens The Endgame
Read more
Catharina Boehme: «Il y a une crise évidente dans la disponibilité des tests du coronavirus»
Read more
COVID-19 Coronavirus And Tuberculosis: We Need A Damage Control Plan
Read more